This suggested that knockdown of Exo70 or ES2 treatment promoted the aggregation of MVBs in the intracellular space and prevented the fusion of MVBs with lipid membranes, which in turn reduced the release of exosomes from pancreatic cancer cells. Here, EXOC7 is linked to familial pancreatic carcinoma.